INDIVINA

This brand name is authorized in Germany, Estonia, Finland, Ireland, Poland, United Kingdom

Active ingredients

The drug INDIVINA contains a combination of these active pharmaceutical ingredients (APIs):

1 Estradiol UNII OKG364O896 - ESTRADIOL VALERATE

Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. Read about Estradiol

2 Medroxyprogesterone UNII C2QI4IOI2G - MEDROXYPROGESTERONE ACETATE

Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects. Read about Medroxyprogesterone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03FA12	Medroxyprogesterone and estrogen	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03F Progestogens and estrogens in combination → G03FA Progestogens and estrogens, fixed combinations
Discover more medicines within G03FA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01561284, 01561309, 01561350
Country: EE	Ravimiamet	Identifier(s): 1618602, 1680667
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 575290, 575449, 575738
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 142538, 161920, 161922, 161924, 37800, 37803, 38538
Country: IE	Health Products Regulatory Authority	Identifier(s): 29020, 29032, 29054, 29096
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100124265, 100124294, 100124319